Work

A Phase I Study of Safety, Tolerability and Immunological Effects of SVN53-67/M57-KLH in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance Therapy

Year: 2022

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood-2022-163597

Authors: Othman Salim Akhtar, Jens Hillengass, Brea Lipe, Sheila A. Figel, Robert A. Fenstermaker, Michael J. Ciesielski, Kelvin P. Lee

Institutions: Moffitt Cancer Center, Roswell Park Comprehensive Cancer Center, University of Rochester Medicine, Indiana University Health, Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310161846

FWCI: 0.182

Cites:

Cited by: 1

Related to: 10